凝膠電泳的全球市場:2020年∼2024年

全球凝膠電泳的市場規模，在2020年∼2024年間，預測將成長到3億8192萬美元，在預測期間內預計將以5％的年複合成長率增長。

市場成長的主要因素有慢性病和傳染病發病率上升，藥物研究與開發（隨著醫療成本上升，基因組學和蛋白​​質組學研究的增長以及資金的增加）。

本報告提供凝膠電泳的世界市場調查，提供市場形勢和規模，波特的五力分析，各產品及各終端用戶的市場區隔，客戶和各地區形勢，業者情勢，供應商分析等資訊。

目錄

摘要整理

市場形勢

市場規模

• 市場定義
• 市場區隔分析
• 2019年的市場規模
• 市場預測:從2019年∼2024年的預測

波特的五力分析

市場區隔:各產品

• 市場區隔
• 各產品比較
• 消耗品:市場規模與預測(2019年∼2024年)
• 設備:市場規模與預測(2019年∼2024年)
• 各產品的市場機會

市場區隔:各終端用戶

• 市場區隔
• 各終端用戶比較
• 製藥·生物科技:市場規模與預測(2019年∼2024年)
• 其他終端用戶:市場規模與預測(2019年∼2024年)
• 各終端用戶市場機會

客戶形勢

各地區形勢

• 各地區市場區隔
• 各地區比較
• 北美:市場規模與預測(2019年∼2024年)
• 歐洲:市場規模與預測(2019年∼2024年)
• 亞洲:市場規模與預測(2019年∼2024年)
• 其他地區:市場規模與預測(2019年∼2024年)
• 主要國家
• 各地區的市場機會
• 市場推動因素
• 市場課題
• 市場趨勢

業者情勢

• 概要
• 業者情勢
• 創造性破壞狀況

供應商分析

• 交易廠商
• 供應商的市場定位
• Avantor Inc.
• Bio-Rad Laboratories Inc.
• Cleaver Scientific Ltd.
• Cytiva
• Lonza Group Ltd.
• Merck KGaA
• PerkinElmer Inc.
• QIAGEN NV
• Shimadzu Corp.
• Thermo Fisher Scientific Inc.

附錄

Technavio has been monitoring the gel electrophoresis market and it is poised to grow by $ 381.92 mn during 2020-2024 progressing at a CAGR of 5% during the forecast period. Our report on gel electrophoresis market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rising incidences of chronic and infectious diseases, increasing healthcare spending coupled with growing R&D activities for drug development, and growth in research and funding for genomics and proteomics. In addition, rising incidences of chronic and infectious diseases is anticipated to boost the growth of the market as well.

The gel electrophoresis market analysis includes product segment, end-user segment and geographical landscapes.

Technavio's gel electrophoresis market is segmented as below:

By Product

• Consumables
• Equipment

By End-user

• Academic, govt., and other research institutes
• Pharma and biotech companies
• Other end-users

By Geographical Landscapes

• North America
• Europe
• Asia
• ROW

This study identifies the rise in outsourcing activities as one of the prime reasons driving the gel electrophoresis market growth during the next few years. Also, rapid growth potential in emerging economies, and advances in gel electrophoresis will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on gel electrophoresis market covers the following areas:

• Gel electrophoresis market sizing
• Gel electrophoresis market forecast
• Gel electrophoresis market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading gel electrophoresis market vendors that include Avantor Inc., Bio-Rad Laboratories Inc., Cleaver Scientific Ltd., Cytiva, Lonza Group Ltd., Merck KGaA, PerkinElmer Inc., QIAGEN NV, Shimadzu Corp., and Thermo Fisher Scientific Inc.. Also, the gel electrophoresis market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

• Market Overview

Market Landscape

• Market ecosystem
• Market characteristics
• Value chain analysis

Market Sizing

• Market definition
• Market segment analysis
• Market size 2019
• Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

• Five Forces Summary
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

Market Segmentation by Product

• Market segments
• Comparison by Product
• Consumables - Market size and forecast 2019-2024
• Equipment - Market size and forecast 2019-2024
• Market opportunity by Product

Market Segmentation by End-user

• Market segments
• Comparison by End-user
• Pharma and biotech companies - Market size and forecast 2019-2024
• Other end-users - Market size and forecast 2019-2024
• Market opportunity by End-user

Customer Landscape

Geographic Landscape

• Geographic segmentation
• Geographic comparison
• North America - Market size and forecast 2019-2024
• Europe - Market size and forecast 2019-2024
• Asia - Market size and forecast 2019-2024
• ROW - Market size and forecast 2019-2024
• Key leading countries
• Market opportunity by geography
• Market drivers
• Market challenges
• Market trends

Vendor Landscape

• Overview
• Vendor landscape
• Landscape disruption

Vendor Analysis

• Vendors covered
• Market positioning of vendors
• Avantor Inc.
• Bio-Rad Laboratories Inc.
• Cleaver Scientific Ltd.
• Cytiva
• Lonza Group Ltd.
• Merck KGaA
• PerkinElmer Inc.
• QIAGEN NV
• Shimadzu Corp.
• Thermo Fisher Scientific Inc.

Appendix

• Scope of the report
• Currency conversion rates for US$
• Research methodology
• List of abbreviations

Exhibit

• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Key Finding 9
• 9: Parent market
• 10: Market characteristics
• 11: Offerings of vendors included in the market definition
• 12: Market segments
• 13: Global - Market size and forecast 2019 - 2024 ($ million)
• 14: Global market: Year-over-year growth 2019 - 2024 (%)
• 15: Five forces analysis 2019 & 2024
• 16: Bargaining power of buyers
• 17: Bargaining power of suppliers
• 18: Threat of new entrants
• 19: Threat of substitutes
• 20: Threat of rivalry
• 21: Market condition - Five forces 2019
• 22: Product - Market share 2019-2024 (%)
• 23: Comparison by Product
• 24: Consumables - Market size and forecast 2019-2024 ($ million)
• 25: Consumables - Year-over-year growth 2019-2024 (%)
• 26: Equipment - Market size and forecast 2019-2024 ($ million)
• 27: Equipment - Year-over-year growth 2019-2024 (%)
• 28: Market opportunity by Product
• 29: End user - Market share 2019-2024 (%)
• 30: Comparison by End user
• 31: Academic, govt., and other research institutes - Market size and forecast 2019-2024 ($ million)
• 32: Academic, govt., and other research institutes - Year-over-year growth 2019-2024 (%)
• 33: Pharma and biotech companies - Market size and forecast 2019-2024 ($ million)
• 34: Pharma and biotech companies - Year-over-year growth 2019-2024 (%)
• 35: Other end-users - Market size and forecast 2019-2024 ($ million)
• 36: Other end-users - Year-over-year growth 2019-2024 (%)
• 37: Market opportunity by End user
• 38: Customer landscape
• 39: Market share by geography 2019-2024 (%)
• 40: Geographic comparison
• 41: North America - Market size and forecast 2019-2024 ($ million)
• 42: North America - Year-over-year growth 2019-2024 (%)
• 43: Europe - Market size and forecast 2019-2024 ($ million)
• 44: Europe - Year-over-year growth 2019-2024 (%)
• 45: Asia - Market size and forecast 2019-2024 ($ million)
• 46: Asia - Year-over-year growth 2019-2024 (%)
• 47: ROW - Market size and forecast 2019-2024 ($ million)
• 48: ROW - Year-over-year growth 2019-2024 (%)
• 49: Key leading countries
• 50: Market opportunity by geography ($ million)
• 51: Impact of drivers and challenges
• 52: Vendor landscape
• 53: Landscape disruption
• 54: Industry risks
• 55: Vendors covered
• 56: Market positioning of vendors
• 57: Avantor Inc. - Overview
• 58: Avantor Inc. - Business segments
• 59: Avantor Inc. - Key offerings
• 60: Avantor Inc. - Key customers
• 61: Avantor Inc. - Segment focus
• 62: Bio-Rad Laboratories Inc. - Overview
• 63: Bio-Rad Laboratories Inc. - Business segments
• 64: Bio-Rad Laboratories Inc. - Key offerings
• 65: Bio-Rad Laboratories Inc. - Key customers
• 66: Bio-Rad Laboratories Inc. - Segment focus
• 67: Cleaver Scientific Ltd. - Overview
• 68: Cleaver Scientific Ltd. - Product and service
• 69: Cleaver Scientific Ltd. - Key offerings
• 70: Cleaver Scientific Ltd. - Key customers
• 71: Cleaver Scientific Ltd. - Segment focus
• 72: Cytiva - Overview
• 73: Cytiva - Product and service
• 74: Cytiva - Key offerings
• 75: Cytiva - Key customers
• 76: Cytiva - Segment focus
• 77: Lonza Group Ltd. - Overview
• 78: Lonza Group Ltd. - Business segments
• 79: Lonza Group Ltd. - Key offerings
• 80: Lonza Group Ltd. - Key customers
• 81: Lonza Group Ltd. - Segment focus
• 82: Merck KGaA - Overview
• 83: Merck KGaA - Business segments
• 84: Merck KGaA - Key offerings
• 85: Merck KGaA - Key customers
• 86: Merck KGaA - Segment focus
• 87: PerkinElmer Inc. - Overview
• 88: PerkinElmer Inc. - Business segments
• 89: PerkinElmer Inc. - Key offerings
• 90: PerkinElmer Inc. - Key customers
• 91: PerkinElmer Inc. - Segment focus
• 92: QIAGEN NV - Overview
• 93: QIAGEN NV - Business segments
• 94: QIAGEN NV - Key offerings
• 95: QIAGEN NV - Key customers
• 96: QIAGEN NV - Segment focus
• 97: Shimadzu Corp. - Overview
• 98: Shimadzu Corp. - Business segments
• 99: Shimadzu Corp. - Key offerings
• 100: Shimadzu Corp. - Key customers
• 101: Shimadzu Corp. - Segment focus
• 102: Thermo Fisher Scientific Inc. - Overview
• 103: Thermo Fisher Scientific Inc. - Business segments
• 104: Thermo Fisher Scientific Inc. - Key offerings
• 105: Thermo Fisher Scientific Inc. - Key customers
• 106: Thermo Fisher Scientific Inc. - Segment focus
• 107: Currency conversion rates for US$
• 108: Research Methodology
• 109: Validation techniques employed for market sizing
• 110: Information sources
• 111: List of abbreviations